Massive study reveals best arthritis drug combos for patients
NCT ID NCT05576051
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at over 9,000 people with rheumatoid arthritis to compare how well different treatments work in everyday medical practice. Researchers compared drugs like TNF inhibitors and tofacitinib, given alone or with methotrexate, to see which combination controls disease activity best after 6 months. The goal was to help doctors choose the most effective treatment for each patient.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer
New York, New York, 10017, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new shoulder implant restore Pain-Free movement?
- Can a less invasive hip surgery speed up recovery?
- Which hip implant lasts longer? a Head-to-Head trial aims to find out
- Can pregnancy and neurological disease coexist safely? a new registry seeks answers
- Can group learning make biotherapy safer for arthritis patients?
- Can a specialized hand exercise protocol restore grip and ease pain in rheumatoid arthritis?